PDAC has recently been found to impair NK cell tumor cell recognition and function by the regulation of several mediators, including transforming growth factor beta (TGF-β), interleukin (IL)-10, indoleamine 2,3-dioxygenase (IDO), and matrix metalloproteinases (MMPs) [67]. The gene discussed is TGFB1; the disease is neoplasm.